Lycopene inversely linked to renal cell carcinoma risk

Lycopene inversely linked to renal cell carcinoma risk

(HealthDay)—For postmenopausal women, lycopene intake seems to be inversely associated with the risk of renal cell carcinoma (RCC), according to a study published in the Feb. 15 issue of Cancer.

Won Jin Ho, M.D., from Case Western Reserve University in Cleveland, and colleagues examined the between antioxidant micronutrients and the risk of RCC. Data were included for 96,196 enrolled in the Women's Health Initiative between 1993 and 1998 who were followed through July 2013. A baseline food frequency questionnaire was used to estimate dietary micronutrient intake, and an interview-based inventory procedure was used to collect data on supplement use. Follow-up surveys were used to ascertain RCC cases.

The researchers identified 240 with RCC during follow-up. There was an inverse correlation for lycopene intake with RCC risk (P = 0.015); the highest versus the lowest intake was associated with a 39 percent lower risk of RCC (hazard ratio, 0.61). There were no other correlations for micronutrients with RCC risk.

"The current results suggest that further investigation into the correlation between lycopene intake and the risk of RCC is warranted," the authors write.

Explore further

Soy food, isoflavone intake not linked to endometrial cancer

More information: Abstract
Full Text (subscription or payment may be required)
Journal information: Cancer

Copyright © 2015 HealthDay. All rights reserved.

Citation: Lycopene inversely linked to renal cell carcinoma risk (2015, February 16) retrieved 8 April 2020 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments